Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

GeoVax Labs Inc

GOVX
Current price
2.03 USD -0.16 USD (-7.31%)
Last closed 2.23 USD
ISIN US3736785078
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 17 646 150 USD
Yield for 12 month -74.05 %
1Y
3Y
5Y
10Y
15Y
GOVX
21.11.2021 - 28.11.2021

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; other infectious disease vaccines for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia. Address: 1900 Lake Park Drive, Smyrna, GA, United States, 30080

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

42 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+81 000 USD

Current Quarter

+300 677 USD

Last Quarter

Current Year

-20 720 766 USD

Last Year

+81 000 USD

Current Quarter

+276 934 USD

Last Quarter

-19 576 USD

Key Figures GOVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -27 155 956 USD
Operating Margin TTM -1683.61 %
PE Ratio
Return On Assets TTM -134.35 %
PEG Ratio
Return On Equity TTM -362.39 %
Wall Street Target Price 42 USD
Revenue TTM 300 677 USD
Book Value -0.55 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 81 526 USD
Earnings per share -13.31 USD
Diluted Eps TTM -13.31 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GOVX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GOVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 31.01.2024
Dividend Date 25.09.2020

Stock Valuation GOVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 10.627
Enterprise Value Revenue 53.6262
Price Sales TTM 58.6881
Enterprise Value EBITDA 0.1027
Price Book MRQ 129.5016

Financials GOVX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GOVX

For 52 weeks

1.09 USD 11.18 USD
50 Day MA 3.44 USD
Shares Short Prior Month 261 925
200 Day MA 2.85 USD
Short Ratio 0.02
Shares Short 256 925
Short Percent 3.03 %